Ongoing and published publications from EUnetHTA
OTCA18 Regional hyperthermia for high-risk soft tissue sarcoma treatment. You may find the final report and related documents here.
Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic, or have medical contraindications to such therapies.This is a WP4 Joint Production. You may find the final report and related documents here.